View drug registration information details.

Items	Registration information
ID	329
No	329
Brand Name	LIPIDUCE-20
Ingredients	ATORVASTATIN CALCIUM 21.70 MG EQ.TO ATORVASTATIN 20 MG
Dosage Form	TABLET
Primary Packaging	BLISTERPACK
Storage
Shelf Life	3 YEARS
Pack Size	BOX OF 3 X 10'S
Dispensing Category
ATC Classification
Pharmaceutical Class
Indications	AS AN ADJUNCT THERAPY TO DIET TO REDUCE ELEVATED TOTAL, LDL-CHOLESTEROL, APOLIPOPROTEINE B, TRIGLYCERIDES AND INCREASE HDL-CHOLESTEROL IN PATIENT WITH PRIMARY HYPERCHOLESTEROLEMIA ( HETEROZYGOUS FAMILIAL AND NONFAMILIAL), COMBINED HYPERLIPIDEMIA (FREDRICKSON TYPES IIA AND IIB), PRIMARY DYSETALIPOPROTEINEMIA
Contraindications
Side Effects
Unit Price
EDL	NULL
Description	WHITE COLOURED FILM COATED OVAL SHAPED TABLETS, SHALLOW CONVEX FACES, PLAIN ON BOTH SIDE.
Note
License Owner	BMS PHARMA SOLE CO.,LTD
Manufacturer	HOVID BHD
Country	MALAYSIA
Import Registration No
Import Registration Date
Activity	CERTIFICATE RELEASED
Applied Date
FDD Registration No	04 I 4689/19
FDD Registration Date	07-JUL-2025
Expiry Date	06-JUL-2030

Back to drug list